Page 1 of Clinical Trials for Drug CHOP regimen alternate with ESHAP regimen, 1 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
The Effectiveness of Alemtuzumab Given in Combination With CHOP and ESHAP in Patients Newly Diagnosed With Peripheral T-Cell Lymphoma (PTCL)
Last Updated: October 4, 2011
Condition(s): Peripheral T-cell Lymphoma

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+CHOP+regimen+alternate+with+ESHAP+regimen

CR Health Net sites have been providing trustworthy health information since 2002.

Follow @medfeeds on Twitter

Browse
Clinical Trials Background
- Clinical Trials FAQ
- Clinical Trials Glossary
About
- About and Contact
- RSS Help

This clinical trials RSS facility is brought to you as a free service by Clinical Trials Feeds (ClinicalTrialsFeeds.org), using data supplied by the US National Institutes of Health and ClinicalTrials.gov. You can also check the CR Health Net site RxDrugLabels.com for an easy-to-use database of the latest product labels and prescription medication package inserts from the US Food and Drug Administration.

Page 1 of Clinical Trials for Drug CHOP regimen alternate with ESHAP regimen, 1 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About